🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
316,13 USD
Máx. histórico
322,75
5 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,05%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+0,83%
Cierre anterior
313,52
Rango de hoy
309,86 – 319,18
Volumen hoy
179.912
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 124,46 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 1 hora
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/04/1996 | 50,53 | 58,02 | 49,13 | 55,68 | +11,74% | 17,59% | 178.681 |
| 25/04/1996 | 50,06 | 50,53 | 48,66 | 49,83 | +1,43% | 3,74% | 64.360 |
| 24/04/1996 | 48,19 | 50,53 | 47,72 | 49,13 | +2,94% | 5,83% | 155.758 |
| 23/04/1996 | 47,72 | 47,72 | 46,32 | 47,72 | +0,00% | 2,94% | 42.079 |
| 22/04/1996 | 46,32 | 47,72 | 45,38 | 47,72 | +3,03% | 5,05% | 28.346 |
| 19/04/1996 | 47,26 | 48,19 | 45,38 | 46,32 | +1,02% | 5,94% | 61.154 |
| 18/04/1996 | 45,85 | 47,26 | 45,85 | 45,85 | -0,51% | 3,06% | 16.805 |
| 17/04/1996 | 45,38 | 46,32 | 44,45 | 46,09 | +2,60% | 4,12% | 17.954 |
| 16/04/1996 | 44,92 | 45,38 | 43,51 | 44,92 | +0,00% | 4,17% | 17.927 |
| 15/04/1996 | 43,98 | 44,92 | 43,51 | 44,92 | +2,67% | 3,19% | 20.892 |
| 12/04/1996 | 43,51 | 44,45 | 43,51 | 43,75 | +0,54% | 2,15% | 57.361 |
| 11/04/1996 | 43,98 | 44,45 | 43,51 | 43,51 | -2,11% | 2,13% | 12.637 |
| 10/04/1996 | 44,45 | 44,92 | 43,98 | 44,45 | +0,53% | 2,11% | 46.567 |
| 09/04/1996 | 44,92 | 44,92 | 43,98 | 44,21 | +0,00% | 2,08% | 55.891 |
| 08/04/1996 | 44,92 | 44,92 | 43,98 | 44,21 | -2,58% | 2,08% | 17.873 |
| 04/04/1996 | 45,85 | 45,85 | 43,98 | 45,38 | +0,52% | 4,08% | 30.350 |
| 03/04/1996 | 44,45 | 45,38 | 43,04 | 45,15 | +2,66% | 5,26% | 20.385 |
| 02/04/1996 | 44,45 | 44,45 | 42,58 | 43,98 | +3,30% | 4,21% | 17.393 |
| 01/04/1996 | 43,51 | 44,45 | 41,64 | 42,58 | -2,15% | 6,45% | 27.438 |
| 29/03/1996 | 43,98 | 44,92 | 43,51 | 43,51 | -5,10% | 3,19% | 35.987 |
| 28/03/1996 | 46,79 | 46,79 | 44,45 | 45,85 | +1,03% | 5,00% | 36.335 |
| 27/03/1996 | 45,38 | 46,79 | 45,38 | 45,38 | +0,00% | 3,09% | 20.438 |
| 26/03/1996 | 45,38 | 46,79 | 45,38 | 45,38 | +0,00% | 3,09% | 22.202 |
| 25/03/1996 | 46,79 | 46,79 | 45,38 | 45,38 | -2,02% | 3,00% | 9.565 |
| 22/03/1996 | 46,79 | 46,79 | 45,38 | 46,32 | -1,00% | 3,00% | 35.720 |
| 21/03/1996 | 46,79 | 46,79 | 45,38 | 46,79 | +1,01% | 3,00% | 24.179 |
| 20/03/1996 | 45,85 | 46,79 | 44,92 | 46,32 | +2,06% | 4,08% | 102.245 |
| 19/03/1996 | 46,79 | 46,79 | 44,45 | 45,38 | +10,23% | 5,00% | 159.258 |
| 18/03/1996 | 40,24 | 43,04 | 40,24 | 41,17 | +2,33% | 6,98% | 129.309 |
| 15/03/1996 | 40,24 | 41,17 | 40,24 | 40,24 | -2,27% | 2,33% | 35.079 |